These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3064242)

  • 21. [Treatment of hypercholesterolemia with enzyme inhibitors].
    Valdés EF
    Medicina (B Aires); 1988; 48(4):425-8. PubMed ID: 3076202
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 24. Step management of hypercholesterolemia.
    Repka FJ; Leighton RF
    Am Fam Physician; 1987 Oct; 36(4):238-48. PubMed ID: 3314439
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive cardiology.
    Reeves WC
    Med Sect Proc; 1989; ():29-37. PubMed ID: 2701587
    [No Abstract]   [Full Text] [Related]  

  • 29. What do the statin trials tell us?
    Waters DD
    Am J Manag Care; 2001 May; 7(5 Suppl):S138-43. PubMed ID: 11383375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease.
    Nag SS; Pearson TA; Ma L; Landsman PB; Cimino A; Vickers FF; Alexander CM; Melin JM
    Am J Cardiol; 2005 Apr; 95(7):862-4. PubMed ID: 15781017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for treatment of high blood cholesterol. The National Cholesterol Education Program Adult Treatment Panel.
    Ernst ND; LaRosa JC
    Bol Asoc Med P R; 1988 Jul; 80(7):258-61. PubMed ID: 3166669
    [No Abstract]   [Full Text] [Related]  

  • 32. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Why the cardiologists should be interested in lipids?].
    López-Sendón JL; Rubio R; López de Sá E; Delcán JL
    Rev Esp Cardiol; 1995; 48 Suppl 2():23-32. PubMed ID: 7569272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid disorders: when--and why--you should treat at-risk adults.
    Gamble CL
    Geriatrics; 1994 Oct; 49(10):33-8. PubMed ID: 7926847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 38. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

  • 39. [Risk factors of ischemic heart disease in practically healthy persons with different physical work capacities and their correction by physical exercise].
    Pirogova EA
    Ter Arkh; 1988; 60(1):20-3. PubMed ID: 3363501
    [No Abstract]   [Full Text] [Related]  

  • 40. [Benefits and costs of early detection and treatment of hypercholesterolemia].
    Laaser U
    Z Kardiol; 1994; 83 Suppl 6():163-7. PubMed ID: 7863690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.